Friday, November 22, 2013 12:25:05 PM
Correvio earned $30million+ per year for global sales of aggrastat...not a serious contender. And they got bought out by a company with a market cap around $70 million.
Hope the annual shareholder meeting (11/26) goes well, if any shareholders show up. Have to vote on their accountants compensation. By the way, bankrupt Savient Pharmaceuticals shares a similar market valuation with Medicure.
Bring on another reverse split.
Recent MCUJF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/05/2023 10:02:35 PM
- Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv • InvestorsHub NewsWire • 08/30/2023 11:00:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM